Home / Health / First Baby Enrolled in Landmark Brain Study
First Baby Enrolled in Landmark Brain Study
2 May
Summary
- A global study is recruiting newborns to research brain injury.
- Cooling therapy is being tested to reduce brain injury in newborns.
- The study aims to improve long-term outcomes for affected infants.
A significant global research initiative is underway to improve the prognosis for newborns suffering from brain injuries at birth. The COMET (Cooling in Mild Encephalopathy Trial) study, spearheaded by Imperial College London and funded by the National Institute for Health and Care Research, has recently recruited its first participant, Eliza. This trial focuses on the efficacy of cooling therapy in reducing brain injury in infants diagnosed with hypoxic ischaemic encephalopathy (HIE), a condition impacting roughly one in every 1,000 newborns.
Eliza, who was born last October, was identified with mild HIE due to symptoms like rapid breathing and delayed reflexes. Her parents opted to enroll her in the study after considering the potential benefits. The therapeutic approach involves carefully lowering a baby's temperature to 33.5ºC for three days using a special cooling blanket or mattress. This intervention is crucial for potentially preventing the lasting cognitive and neurological challenges that can arise from HIE, approximately 20% of affected infants facing lifelong disabilities.
This study is vital for shifting the approach to mild HIE diagnoses, moving away from a passive wait-and-see strategy. Experts emphasize the importance of widespread participation across NHS hospitals to ensure all babies receive the best possible start and parents can make informed decisions about their child's care.
